NR1H4 and metabolic dysfunction-associated steatotic liver disease: Activating FXR proves instrumental in regulating lipid metabolism within liver cells, controlling the release of inflammatory cytokines, alleviating liver inflammation, and impeding crucial processes in NAFLD, such as the formation of hepatic stellate cells and fibrosis.